BIO-B Stock 12 Month Analyst Forecast
Eps Overview
Growth Next 5yrs
N/A
Last Quarter
$23.34
Past Year
-
Growth Past 5yrs
N/A
Next Quarter
-
Estimate Next Year
-
Consensus Rating
Loading...
Consensus Price Target
Highest Price Target
N/A
(
0% Upside
)Mean Price Target
N/A
(
0% Upside
)Lowest Price Target
N/A
(
0% Upside
)Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Actual EPS vs Estimated EPS
BIO-B Earnings Per Share (EPS) History
According to financial reports, BIO-B (NYSE: BIO-B) reported an actual EPS of $23.34 for the quarter ending on Oct 30, 2024, compared to an estimated $1.13, resulting in a 1965.49% surprise. In the prior quarter (Aug 01, 2024), BIO-B recorded an actual EPS of $-76.26293 with a -3820.14% surprise. See BIO-B's full earnings history.
Earnings History
EPS Surprise Factor Analysis
BIO-B has experienced notable EPS surprises, with the latest quarter ending Oct 30, 2024 showing a 1965.49% beat. Previously, the quarter ending Aug 01, 2024 recorded a -3820.14% miss. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
Frequently Asked Questions
Is BIO-B stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given BIO-B stock an average recommendation of
N/A. 0 analysts have given their ratings
to BIO-B out of which
0 analysts have given strong buy call,
0 analysts have given buy call,
0 analysts rate it hold,
0 analysts advocate strong sell call, and
0 analysts has given sell rating. The average target price of
- gives the stock implied downside
of roughly 0% over the next year or so.
What have analysts suggested for BIO-B highest price target?
Analysts suggest BIO-B's stock price would rise to a high of -.
What is the lowest price target analysts expect for BIO-B over the next year?
Within the next 12 months, analysts predict the BIO-B stock price could move to -.
What is the average target price for BIO-B?
BIO-B stock has an average analyst estimate of -.
At its current price, how far is BIO-B from its average target price?
BIO-B shares are currently trading 0% below this price target.
What were BIO-B’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at $23.34 versus consensus estimates of $1.13, and above the comparable year-ago quarter’s EPS of $1.61.
What are the current estimates for quarterly and annual earnings per share?
BIO-B's forecasts by analysts estimating quarterly EPS at - and - for the whole year.
What has BIO-B's growth been in the past five years and what is expected in the next five years?
The analysts have projected N/A EPS growth for BIO-B in the next five years, compared to growth rates of N/A in the past five years.